Return to homepagePandemic Pact

LungchildMSC stromal mesenchymal cell secretoma in chronic pulmonary diseases: validation of an innovative approach to care for covid-induced pulmonary fibrosis 19

  • Funded by Ministry of Education, University and Research Italy
  • Total publications:3 publications

Grant number: FISR2020IP_02959

Grant search

Key facts

  • Disease

    COVID-19

  • Known Financial Commitments (USD)

    $64,751.61

  • Funder

    Ministry of Education, University and Research Italy

  • Principal Investigator

    N/A

  • Research Location

    Italy

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Disease pathogenesis

  • Special Interest Tags

    Innovation

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Bone Marrow Mesenchymal Stem Cells Expanded Inside the Nichoid Micro-Scaffold: a Focus on Anti-Inflammatory Response.

Mesenchymal Stromal Cells for the Treatment of Interstitial Lung Disease in Children: A Look from Pediatric and Pediatric Surgeon Viewpoints.

SARS-CoV-2 Exposed Mesenchymal Stromal Cell from Congenital Pulmonary Airway Malformations: Transcriptomic Analysis and the Expression of Immunomodulatory Genes.